Back
ProShares UltraPro Short QQQ Vs. NovoCure Industry Stock Comparison
Sell
30
SQQQ
ProShares UltraPro Short QQQ
Last Price:
31.27
Seasonality Move:
-15.84%
Buy
82
NVCR
NovoCure
Last Price:
30.52
Seasonality Move:
2.04%
Sell
30
ProShares UltraPro Short QQQ (SQQQ)
is a Sell
Is ProShares UltraPro Short QQQ a Buy, Sell or Hold?
- The current ProShares UltraPro Short QQQ [SQQQ] share price is $31.25. The Score for SQQQ is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SQQQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SQQQ Stock Price Chart
What is ProShares UltraPro Short QQQ's stock price today?
-
The ProShares UltraPro Short QQQ share price today is $31.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SQQQ is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Stock Price Chart
SQQQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.97 | Sell |
| Relative Strength Index (14 RSI): | 36.1 | Sell |
| Chaikin Money Flow: | -20960834 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.76 - 35.58) | Sell |
| Bollinger Bands (100): | (34.08 - 44.62) | Sell |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 84.56 | Buy |
| Chaikin Money Flow: | -690353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.69 - 22.01) | Buy |
| Bollinger Bands (100): | (15.44 - 20.28) | Buy |
SQQQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.65 | Sell |
| 20-day SMA: | 32.95 | Sell |
| 50-day SMA: | 35.17 | Sell |
| 200-day SMA: | 45.08 | Sell |
| 8-day EMA: | 32.44 | Sell |
| 20-day EMA: | 33.3 | Sell |
| 50-day EMA: | 35.42 | Sell |
| 200-day EMA: | 48.96 | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.45 | Buy |
| 20-day SMA: | 18.85 | Buy |
| 50-day SMA: | 17.12 | Buy |
| 200-day SMA: | 17.34 | Buy |
| 8-day EMA: | 23.1 | Buy |
| 20-day EMA: | 19.92 | Buy |
| 50-day EMA: | 18.23 | Buy |
| 200-day EMA: | 19.07 | Buy |
ProShares UltraPro Short QQQ Earnings Growth & SQQQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
ProShares UltraPro Short QQQ Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||